Movicol and Cosentyx drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Movicol (polyethylene glycol 3350) and Cosentyx (secukinumab). Common drug interactions include mass among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Movicol and Cosentyx. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Cosentyx?

Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 187,247 Cosentyx users. Check the latest studies of Cosentyx.



On Jul, 31, 2026

36 people who take Movicol and Cosentyx together, and have interactions are studied.

Movicol and Cosentyx drug interactions.

What are the common drug interactions of Movicol and Cosentyx, by gender? *:

female:

  1. Mass
  2. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Osteonecrosis (death of bone)
  4. Pickwickian syndrome (extreme obesity accompanied by sleepiness, hypoventilation, and polycythemia)
  5. Pyelonephritis (inflammation of kidney caused by bacteria)
  6. Pyrexia (fever)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Septic shock (shock due to blood infection)
  9. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  10. Sputum discoloured

male:

  1. Haemoglobin decreased
  2. Metastases to bone (cancer spreads to bone)
  3. Inflammatory marker increased
  4. Intraocular pressure increased
  5. Nausea (feeling of having an urge to vomit)
  6. Ocular fistula (an abnormal connection or passageway in eye)
  7. Open angle glaucoma (an eye disease that gradually steals vision)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Polyp
  10. Streptococcal infection

What are the common drug interactions of Movicol and Cosentyx, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal discomfort
  2. Arthralgia (joint pain)
  3. Diarrhoea
  4. Groin pain
  5. Headache (pain in head)
  6. Infection
  7. Injection site pruritus (severe itching at injection site)
  8. Injection site urticaria (rash of round, red welts on the skin at injection site)
  9. Joint swelling
  10. Malaise (a feeling of general discomfort or uneasiness)

40-49:

  1. Abdominal pain
  2. Abdominal pain lower
  3. Abdominal pain upper
  4. Colitis (inflammation of colon)
  5. Colitis ulcerative (inflammation of colon with ulcer)
  6. Diarrhoea
  7. Hypokalaemia (low potassium)
  8. Pain
  9. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  10. Spinal osteoarthritis (joint cartilage loss in spine)

50-59:

  1. Metastases to bone (cancer spreads to bone)
  2. Angiodysplasia (small vascular malformation of the gut)
  3. C-reactive protein increased
  4. Chronic gastritis (long lasting infection of stomach lining)
  5. Haematocrit decreased
  6. Haemoglobin decreased
  7. Lymphocytic infiltration (lymphocyte deposition)
  8. Metastases to liver (cancer spreads to liver)
  9. Platelet count increased
  10. Red blood cell count decreased

60+:

  1. Eosinophilic pneumonia (eosinophil accumulates in the lung)
  2. Endophthalmitis (inflammation of the internal coats of the eye)
  3. Intraocular pressure increased
  4. Nausea (feeling of having an urge to vomit)
  5. Ocular fistula (an abnormal connection or passageway in eye)
  6. Open angle glaucoma (an eye disease that gradually steals vision)
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Polyp
  9. Streptococcal infection
  10. Vitreous prolapse

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 18 people, 50.00%
  2. Psoriasis (immune-mediated disease that affects the skin): 14 people, 38.89%
  3. High Blood Pressure: 6 people, 16.67%
  4. Sleep Disorder: 5 people, 13.89%
  5. Pain: 5 people, 13.89%
  6. Multi-Vitamin Deficiency (lack of vitamins): 5 people, 13.89%
  7. Arrhythmias (irregular heartbeat): 5 people, 13.89%
  8. Stress And Anxiety: 5 people, 13.89%
  9. Gastrointestinal Motility Disorder (abnormal intestinal contractions): 5 people, 13.89%
  10. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 13.89%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and Cosentyx?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Movicol and Cosentyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cosentyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Movicol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cosentyx and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 and secukinumab (the active ingredients of Movicol and Cosentyx, respectively), and Movicol and Cosentyx (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: